It is therefore also likely that the CD8+ T cells generated following IR/DSR-6434 treatment are specific for TAAs present not only on the irradiated tumor cells, but also those metastatic tumors developing in the lung that are not irradiated. The gene discussed is CD8A; the disease is metastatic neoplasm.